QIAGEN Expands Integrated Coronavirus NGS and Software Solutions to Accelerate COVID-19 ResearchBusiness Wire • 08/18/20
QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls ShortBusiness Wire • 08/13/20
Thermo Fisher Increases Its Buyout Price for Qiagen, but Investors Ask for MoreThe Motley Fool • 08/04/20
Davidson Kempner[1] Now Holds an 8.0% Stake and Finds Qiagen's Standalone Prospects Highly AttractivePRNewsWire • 08/03/20
Davidson Kempner Expects Thermo Fisher Scientific's Current Offer for QIAGEN N.V. to FailPRNewsWire • 07/28/20
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo FisherBusiness Wire • 07/22/20
Qiagen (QGEN) Up 4.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/20